Literature DB >> 27722987

A promising prediction model for survival in gallbladder carcinoma patients: pretreatment prognostic nutrient index.

Yan Deng1, Qing Pang1, Jian-Bin Bi1, Xing Zhang1, Ling-Qiang Zhang2, Yan-Yan Zhou1, Run-Chen Miao1, Wei Chen1, Kai Qu1, Chang Liu3.   

Abstract

The pretreatment nutritional and immunological status play indispensable roles in predicting the outcome of patients with various types of malignancies. The aim of the study was to investigate whether preoperative prognostic nutritional index (PNI), which simply accounts for nutritional and immunological status, was associated with overall survival (OS) in patients with gallbladder carcinoma (GBC). The retrospective study included a total of 315 GBC patients after surgery between 2002 and 2012. PNI was calculated according to the following formula: 10× serum albumin (g/dl) +0.005× total lymphocyte count (per mm3). A receiver operating characteristic (ROC) curve for survival prediction was plotted to verify the optimal cutoff value for LMR, which was set at 46.14. According the value, patients were categorized into two different groups, namely high-PNI group (n = 133) and low-PNI group (n = 182). The univariate and multivariate Cox regression models were used to identify the independent prognostic factors. The results showed that low pretreatment PNI value was significantly associated with elderly age, partial surgery procedure, and advanced tumor status such as tumor stage, node stage, and tumor-node-metastasis stage (P < 0.05). The low-PNI group had a worse OS compare with the high-PNI group (P < 0.05). Via univariate and multivariate analyses, pretreatment PNI was identified as an independent prognostic factor for OS [HR: 0.613; 95%CI: 0.448-0.838; P < 0.001]. Subgroup analyses further revealed that PNI was significantly associated with postoperative OS independent of tumor node metastasis stage and surgical procedure. In conclusion, pretreatment PNI might serve as an effective predictor to evaluate prognosis of GBC patients after surgery. Based on the findings, PNI, characterized with accessibility, objectivity and noninvasiveness, should be included in the routine assessment of GBC.

Entities:  

Keywords:  Albumin; Gallbladder carcinoma; Lymphocyte count; Overall survival; Prognostic nutritional index

Year:  2016        PMID: 27722987     DOI: 10.1007/s13277-016-5396-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.

Authors:  Q Qi; Y Geng; M Sun; P Wang; Z Chen
Journal:  Pancreatology       Date:  2015-01-10       Impact factor: 3.996

3.  Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy.

Authors:  Hwang Gyun Jeon; Don Kyoung Choi; Hyun Hwan Sung; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han-Yong Choi; Hyun Moo Lee
Journal:  Ann Surg Oncol       Date:  2015-06-05       Impact factor: 5.344

4.  Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.

Authors:  Reza Mehrazin; Robert G Uzzo; Alexander Kutikov; Karen Ruth; Jeffrey J Tomaszewski; Essel Dulaimi; Serge Ginzburg; Philip H Abbosh; Timothy Ito; Anthony T Corcoran; David Y T Chen; Marc C Smaldone; Tahseen Al-Saleem
Journal:  Urol Oncol       Date:  2014-07-11       Impact factor: 3.498

5.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

6.  Novel immunological and nutritional-based prognostic index for gastric cancer.

Authors:  Kai-Yu Sun; Jian-Bo Xu; Shu-Ling Chen; Yu-Jie Yuan; Hui Wu; Jian-Jun Peng; Chuang-Qi Chen; Pi Guo; Yuan-Tao Hao; Yu-Long He
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  Preoperative Nutritional Risk Index to predict postoperative survival time in primary liver cancer patients.

Authors:  Yacong Bo; Mingjie Yao; Ling Zhang; Wolde Bekalo; Weiquan Lu; Quanjun Lu
Journal:  Asia Pac J Clin Nutr       Date:  2015       Impact factor: 1.662

8.  Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer.

Authors:  Nan Jiang; Jing-Yu Deng; Xue-Wei Ding; Bin Ke; Ning Liu; Ru-Peng Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

9.  Significance of Onodera's prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution.

Authors:  Chen Jian-Hui; Edward Arthur Iskandar; Sh-Irong Cai; Chuang-Qi Chen; Hui Wu; Jian-Bo Xu; Yu-Long He
Journal:  Tumour Biol       Date:  2015-10-05

10.  Clinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients.

Authors:  Kwang Yeol Paik; In Kyu Lee; Yoon Suk Lee; Na Young Sung; Taek Soo Kwon
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

View more
  2 in total

1.  Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Megumi Watanabe; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis.

Authors:  Jiawen Zhao; Weijia Huang; Yongxian Wu; Yihuan Luo; Bo Wu; Jiwen Cheng; Junqiang Chen; Deyun Liu; Chengyang Li
Journal:  Cancer Cell Int       Date:  2020-01-10       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.